JPRN-UMIN000026338已完成未知
The efficacy of the Lysophosphatidylcholine for atopic dermatitis with facial acne or folliculitis: A Multicenter, Randomized, Double-blind Trial - The efficacy of the Lysophosphatidylcholine for atopic dermatitis with facial acne or folliculitis: A Multicenter, Randomized, Double-blind Trial
Yokohama City University Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2017年2月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients who are classified as the most severe atopic dermatitis. (2)Patients who are under treatments of UV therapy or immunosuppressant drugs for atopic dermatitis. (3)Patients who need to start new antihistamines. (4)Patients taking antibiotics. (5)In addition, patients who are inappropriate as subjects defined by doctors.
研究者
相似试验
已完成
3 期
Tooth cavity disinfetion with Chitosan solution in 5-12 year old childreCTRI/2023/06/053795Dr Sreejeeta Dey96
已完成
不适用
Safety and efficacy of polyphosphate for the treatment of ulcerative colitis(AMU002-CR01)JPRN-UMIN000021555Asahikawa Medical University10
进行中（未招募）
1 期
Intraläsionelle Phospatidylcholin-Injektionen zur Reduktion von Körperfett:Halbseitenvergleichsstudie: Messung der subkutanen Fettschichtdicke mit dem Lipometer (Pilotstudie) - phosphatidylcholin fettreduktioReithosen-Fettverteilungstyp an den Lateralseiten der OberschenkelEUCTR2006-000371-15-ATno sponsor for this trial20
终止
3 期
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)Ulcerative ColitisNCT02849951Prometheus Laboratories25
进行中（未招募）
1 期
.a.EUCTR2021-003437-10-ITAzienda Socio Sanitaria Territoriale di Lodi20